Scarica l'app Stockscreener
2.43
12.75%
-0.355
Dopo l'orario di chiusura:
2.50
0.07
+2.88%
Panoramica
Notizia
Cronologia dei prezzi
Perché EVO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$2.785
Aprire:
$2.75
Volume 24 ore:
158.80K
Relative Volume:
2.46
Capitalizzazione di mercato:
$863.11M
Reddito:
$863.66M
Utile/perdita netta:
$-225.27M
Rapporto P/E:
-3.8316
EPS:
-0.6342
Flusso di cassa netto:
$-63.28M
1 W Prestazione:
-16.78%
1M Prestazione:
-10.66%
6M Prestazione:
-37.21%
1 anno Prestazione:
-40.29%
Intervallo 1D:
$2.33
$2.78
Intervallo di 1 settimana:
$2.33
$2.925
Portata 52W:
$2.308
$4.415
Evotec Se Adr Stock (EVO) Company Profile
Compare EVO vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVO
Evotec Se Adr
|
2.43 | 989.20M | 863.66M | -225.27M | -63.28M | -0.6342 |
TAK
Takeda Pharmaceutical Co Adr
|
16.49 | 52.88B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.86 | 42.98B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.18 | 38.37B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.39 | 31.68B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
535.57 | 23.22B | 3.17B | 1.29B | 1.01B | 27.09 |
Evotec Se Adr Stock (EVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Ripresa | H.C. Wainwright | Buy |
| 2026-02-03 | Iniziato | Berenberg | Buy |
| 2025-04-24 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2024-10-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-08 | Downgrade | Deutsche Bank | Hold → Sell |
| 2024-07-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-07-11 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-01-18 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-06-23 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-16 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-06-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-04-04 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2022-12-09 | Iniziato | H.C. Wainwright | Buy |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-08-10 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2022-01-07 | Ripresa | Citigroup | Neutral |
Mostra tutto
Evotec Se Adr Borsa (EVO) Ultime notizie
Evotec stock. Thin source set keeps the focus on business context. - ad-hoc-news.de
EVTA Forecast — Price Target — Prediction for 2027 - TradingView
100% Profit Potential in Sight: Vidac Pharma's Chance to Double vs Bayer and Evotec - news.financial
Weight-Loss Injections, Cancer Cell Inhibitors & the Power of Algorithms: Adding Potential to Your Portfolio with Novo Nordisk, Vidac Pharma, and Evotec - news.financial
Evotec consensus picture on Wall Street, shares trade as ADR on NASDAQ - ad-hoc-news.de
Evotec launches J.TRAIN for biologics manufacturing - grafa.com
Evotec consensus picture on Nasdaq EVO, shares hover around 2.74 dollars - ad-hoc-news.de
A0QZ3J Forecast — Price Target — Prediction for 2027 - TradingView
Evotec SE Sponsored ADR Actuals & Estimates (NASDAQ:EVO) - TradingView
Evotec refines analyst expectations, shares trade under 5 euros on Xetra - AD HOC NEWS
Evotec shows weak June performance, analyst consensus points above current shares - AD HOC NEWS
Evotec Stockweekly review and sector comparison - Ad-hoc-news.de
Which stock to buy now? Evotec, Nel, and Lahontan Gold in focus - news.financial
Evotec (EVO) Stock Price, News & Analysis $EVO - MarketBeat
Evotec SE Stock (DE0005664809): Short Interest Eases While Shares Trade Near Lows - AD HOC NEWS
Earnings call transcript: Evotec Q1 2026 sees revenue drop amid market challenges - Investing.com
Evotec Q1 2026 slides: revenue drops 22% as transformation accelerates - Investing.com
Evotec reports wider quarterly loss, misses revenue expectations By Investing.com - Investing.com Nigeria
Evotec SE stock (DE0005664809): After CEO exit and audit delay, investors watch turnaround plans - AD HOC NEWS
EVOEvotec SE ADR Stock Price and Quote - Finviz
Evotec ADR Slides 4.3% as Selling Pressure Tests Key Support LevelsQuality Factor - The Legal Advocate
Takeover Candidates for 2026! The Life Sciences Sector Is Heating Up: Evotec, BioNxt Solutions, BioNTech, and Formycon in Focus! - news.financial
BUY RECOMMENDATIONS for RENK and Desert Gold! SHOCK for Evotec! - news.financial
Evotec SE stock (DE0005664809): Steady FY 2025 results amid US expansion - AD HOC NEWS
Evotec AG Earnings Call Balances Pain With Promise - The Globe and Mail
Evotec SE stock (DE0005664809): Drug discovery leader eyes US biotech growth - AD HOC NEWS
Evotec places €116.1 million convertible bonds due 2033 - Investing.com UK
Evotec places €116.1 million convertible bonds due 2033 By Investing.com - Investing.com South Africa
Evotec SE stock (DE0005664809): Recent price gains signal short-term momentum - AD HOC NEWS
Evotec SE stock (DE0005664809): HC Wainwright cuts Q2 earnings outlook - AD HOC NEWS
Boyd Gaming posts downbeat Q1 results, joins Coursera, Evotec and other big stocks moving lower in Friday's pre-market session - MSN
Evotec SE stock (DE0005664809): Q1 2026 results show sharp revenue drop amid restructuring - AD HOC NEWS
Take note! The stock market is (still) ignoring key developments at Desert Gold, Evotec, and Mutares! - news.financial
Evotec Q1 2026 slides: revenue drops 22% as transformation accelerates By Investing.com - Investing.com Nigeria
Earnings call transcript: Evotec Q1 2026 sees revenue drop amid market challenges By Investing.com - Investing.com South Africa
Evotec reports wider quarterly loss, misses revenue expectations - Investing.com
Evotec's Share Price Surges! Summer Rally for Desert Gold? Rheinmetall Shares Heading Toward EUR 2,000? - news.financial
Evotec & Almirall nominate dermatology development candidate - grafa.com
Evotec SE Stock (DE0005664809): Q1 2026 Results Due Today - AD HOC NEWS
Evotec Se Adr Azioni (EVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.13%
1.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):